BP’s ResMed RMD Stock Holding History

BP’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,458	Closed	-$852K	–	426
2021 Q2	$852K	Sell	3,458 -1,436	-29%	-$302K	0.04%	275
2021 Q1	$950K	Sell	4,894 -916	-16%	-$184K	0.03%	309
2020 Q4	$1.24M	Sell	5,810 -5,970	-51%	-$1.19M	0.04%	282
2020 Q3	$2.02M	Sell	11,780 -2,920	-20%	-$539K	0.05%	292
2020 Q2	$2.82M	Hold	14,700	–	–	0.1%	202
2020 Q1	$2.17M	Hold	14,700	–	–	0.09%	214
2019 Q4	$2.28M	Hold	14,700	–	–	0.08%	268
2019 Q3	$1.99M	Buy	+14,700	New	+$1.93M	0.07%	290
2019 Q1	–	Sell	-17,000	Closed	-$1.94M	–	436
2018 Q4	$1.94M	Hold	17,000	–	–	0.08%	252
2018 Q3	$1.96M	Hold	17,000	–	–	0.06%	319
2018 Q2	$1.76M	Hold	17,000	–	–	0.06%	345
2018 Q1	$1.67M	Hold	17,000	–	–	0.06%	331
2017 Q4	$1.44M	Hold	17,000	–	–	0.05%	365
2017 Q3	$1.31M	Buy	+17,000	New	+$1.3M	0.05%	369

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BP's RMD Position: Q3 2021 in Review

BP sold out of ResMed (RMD) in Q3 2021, closing a stake of 3,458 shares — an estimated $852K sold.

BP first reported a position in RMD in Q3 2017 and held it in 14 quarters. The position peaked at $2.82M in Q2 2020. 686 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

BP reported no remaining ResMed position as of Q3 2021 after selling out during the quarter.
BP sold 3,458 ResMed shares in Q3 2021, an estimated $852K.
BP first reported a position in ResMed in Q3 2017 and held it in 14 quarters.
BP's ResMed position peaked at $2.82M in Q2 2020.
686 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.